Abacus Planning Group, Inc. Bristol Myers Squibb CO Transaction History

Abacus Planning Group, Inc.

$552 Million
Q4 2024

A detailed history of Abacus Planning Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Abacus Planning Group, Inc. holds 5,944 shares of BMY stock, worth $332,685. This represents 0.06% of its overall portfolio holdings.

Number of Shares

5,944

Previous 5,924 0.34%

Holding current value

$332,685

Previous $306,000 9.8%

% of portfolio

0.06%

Previous 0.06%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	BUY	$51.92 - $59.94 $1,038 - $1,198	20 Added 0.34%	5,944 $336,000
Q3 2024 Oct 02, 2024	SELL	$39.66 - $51.75 $8,804 - $11,488	-222 Reduced 3.61%	5,924 $306,000
Q2 2024 Jul 30, 2024	SELL	$40.25 - $52.99 $171,988 - $226,426	-4,273 Reduced 41.01%	6,146 $255,000
Q1 2024 Apr 11, 2024	BUY	$47.98 - $54.4 $91,209 - $103,414	1,901 Added 22.32%	10,419 $565,000
Q4 2023 Jan 19, 2024	SELL	$48.48 - $57.85 $115,043 - $137,278	-2,373 Reduced 21.79%	8,518 $437,000
Q3 2023 Oct 11, 2023	SELL	$57.89 - $64.73 $42,317 - $47,317	-731 Reduced 6.29%	10,891 $632,000
Q2 2023 Jul 06, 2023	BUY	$63.71 - $70.74 $50,585 - $56,167	794 Added 7.33%	11,622 $743,000
Q1 2023 Apr 17, 2023	SELL	$65.71 - $74.53 $7,885 - $8,943	-120 Reduced 1.1%	10,828 $750,000
Q4 2022 Jan 19, 2023	BUY	$68.48 - $81.09 $66,357 - $78,576	969 Added 9.71%	10,948 $0
Q3 2022 Oct 18, 2022	BUY	$0.13 - $76.84 $20 - $12,294	160 Added 1.63%	9,979 $709,000
Q2 2022 Jul 18, 2022	BUY	$72.62 - $79.98 $12,563 - $13,836	173 Added 1.79%	9,819 $756,000
Q1 2022 Apr 13, 2022	SELL	$61.48 - $73.72 $4,979 - $5,971	-81 Reduced 0.83%	9,646 $704,000
Q4 2021 Jan 18, 2022	SELL	$53.63 - $62.52 $8,741 - $10,190	-163 Reduced 1.65%	9,727 $606,000
Q3 2021 Oct 19, 2021	BUY	$59.17 - $69.31 $3,431 - $4,019	58 Added 0.59%	9,890 $585,000
Q2 2021 Jul 20, 2021	SELL	$61.91 - $67.42 $24,702 - $26,900	-399 Reduced 3.9%	9,832 $657,000
Q1 2021 Apr 27, 2021	SELL	$59.34 - $66.74 $5,934 - $6,673	-100 Reduced 0.97%	10,231 $646,000
Q2 2020 Aug 11, 2020	BUY	$54.82 - $64.09 $8,223 - $9,613	150 Added 1.47%	10,331 $607,000
Q1 2020 Apr 30, 2020	BUY	$46.4 - $67.43 $57,860 - $84,085	1,247 Added 13.96%	10,181 $567,000
Q4 2019 Jan 30, 2020	BUY	$49.21 - $64.19 $3,395 - $4,429	69 Added 0.78%	8,934 $573,000
Q3 2019 Nov 01, 2019	BUY	$42.77 - $50.71 $47,517 - $56,338	1,111 Added 14.33%	8,865 $450,000
Q2 2019 Aug 12, 2019	BUY	$44.62 - $49.34 $2,186 - $2,417	49 Added 0.64%	7,754 $352,000
Q4 2018 Feb 15, 2019	BUY	$48.76 - $63.23 $223,662 - $290,036	4,587 Added 147.11%	7,705 $401,000
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $223,662 - $290,036	-4,587 Reduced 59.53%	3,118 $253,000
Q4 2018 Jan 25, 2019	SELL	$48.76 - $63.23 $374,476 - $485,606	-7,680 Reduced 49.92%	7,705 $401,000
Q1 2018 May 04, 2018	BUY	$59.92 - $68.98 $184,313 - $212,182	3,076 Added 24.99%	15,385 $973,000
Q4 2017 Mar 06, 2018	BUY	$59.94 - $65.35 $737,801 - $804,393	12,309	12,309 $754,000

Others Institutions Holding BMY

# of Institutions

2,706

Shares Held

1.54B

Call Options Held

32M

Put Options Held

34.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $119B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abacus Planning Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Abacus Planning Group, Inc. with notifications on news.

Account

Abacus Planning Group, Inc. Bristol Myers Squibb CO Transaction History